Comparison of Laboratory Data of Acute Cholangitis Patients Treated with or without Immunosuppressive Drugs.

ISRN gastroenterology Pub Date : 2014-03-10 eCollection Date: 2014-01-01 DOI:10.1155/2014/619628
Minoru Tomizawa, Fuminobu Shinozaki, Rumiko Hasegawa, Yoshinori Shirai, Noboru Ichiki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Makoto Sueishi
{"title":"Comparison of Laboratory Data of Acute Cholangitis Patients Treated with or without Immunosuppressive Drugs.","authors":"Minoru Tomizawa,&nbsp;Fuminobu Shinozaki,&nbsp;Rumiko Hasegawa,&nbsp;Yoshinori Shirai,&nbsp;Noboru Ichiki,&nbsp;Yasufumi Motoyoshi,&nbsp;Takao Sugiyama,&nbsp;Shigenori Yamamoto,&nbsp;Makoto Sueishi","doi":"10.1155/2014/619628","DOIUrl":null,"url":null,"abstract":"<p><p>Objective. Symptoms and laboratory data between acute cholangitis (AC) patients treated with and AC patients treated without immunosuppressive drugs (corticosteroids or methotrexate) were compared to identify factors that can be meaningful to the diagnosis of AC. Methods. The Wilcoxon signed-rank test was used for comparison of baseline variables between the patients with AC treated with immunosuppressive drugs and those without it. The chi-squared test was used in the analysis of the symptoms. Results. In total, 69 patients with AC were enrolled. Fifteen patients were treated with immunosuppressants due to rheumatoid arthritis or other collagen diseases. Jaundice was less frequent in the patients treated with immunosuppressive drugs (P = 0.0351). T-Bil level was marginally lower in the patients treated with immunosuppressants (P = 0.086). AST and ALT levels were lower in the patients treated with immunosuppressants (P = 0.0417 and 0.022, respectively). Conclusions. The frequency of jaundice and AST and ALT levels were lower in the patients treated with immunosuppressive drugs. It is recommended that care be taken to evaluate jaundice, AST level, and ALT level in the diagnosis of AC. </p>","PeriodicalId":89397,"journal":{"name":"ISRN gastroenterology","volume":"2014 ","pages":"619628"},"PeriodicalIF":0.0000,"publicationDate":"2014-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/619628","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/619628","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective. Symptoms and laboratory data between acute cholangitis (AC) patients treated with and AC patients treated without immunosuppressive drugs (corticosteroids or methotrexate) were compared to identify factors that can be meaningful to the diagnosis of AC. Methods. The Wilcoxon signed-rank test was used for comparison of baseline variables between the patients with AC treated with immunosuppressive drugs and those without it. The chi-squared test was used in the analysis of the symptoms. Results. In total, 69 patients with AC were enrolled. Fifteen patients were treated with immunosuppressants due to rheumatoid arthritis or other collagen diseases. Jaundice was less frequent in the patients treated with immunosuppressive drugs (P = 0.0351). T-Bil level was marginally lower in the patients treated with immunosuppressants (P = 0.086). AST and ALT levels were lower in the patients treated with immunosuppressants (P = 0.0417 and 0.022, respectively). Conclusions. The frequency of jaundice and AST and ALT levels were lower in the patients treated with immunosuppressive drugs. It is recommended that care be taken to evaluate jaundice, AST level, and ALT level in the diagnosis of AC.

急性胆管炎患者使用或不使用免疫抑制药物的实验室资料比较。
目标。比较急性胆管炎(AC)患者与未使用免疫抑制药物(皮质类固醇或甲氨蝶呤)治疗的AC患者的症状和实验室数据,以确定对AC诊断有意义的因素。采用Wilcoxon sign -rank检验比较接受免疫抑制药物治疗和未接受免疫抑制药物治疗的AC患者的基线变量。症状分析采用卡方检验。结果。共有69名AC患者入组。15例患者因类风湿关节炎或其他胶原蛋白疾病而接受免疫抑制剂治疗。免疫抑制药物组黄疸发生率较低(P = 0.0351)。免疫抑制剂组T-Bil水平略低于对照组(P = 0.086)。免疫抑制剂组AST和ALT水平较低(P = 0.0417, P = 0.022)。结论。免疫抑制药物组黄疸发生率及AST、ALT水平均较低。建议在诊断AC时注意评估黄疸、AST水平和ALT水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信